we observed a total of 1199subject. Of these, 950 presented with complaints of diarrhoea, vomiting, abdominal pain, melena, hematemesis, rectal discharges and alteration of bowel habits. A total of 818 patients were evaluated in Uganda (Mulago and Arua hospitals) and 381 at Luisa Guidotti Hospital in Zimbabwe. An exhaustive clinical history was collected for each patient and then physical and laboratory examinations were performed. The clinical files of all patients previously admitted to the respective hospitals were obtained and the information taken from these files was then integrated with our clinical findings. Subjects who were found free of gastro-intestinal disease after examinations and did not have a clinical history of infective GI disease but presented with other pathologies, were regarded as control group. The control group was composed of 249 subjects. The subjects who were positive on examination underwent further investigations. The number of patients affected by schistosomiasis and amoebiasis were 221 and 224 respectivelly. The number of patients who suffered from aspecific enterocolitis was 454, intestinal tuberculosis was present in 21 patients and we found 30 patients with esophageal candidiasis. Patients who had the above mentioned GI diseases were then divided into 3 groups. First group was composed of patients who had a clinical history of infective GI diseases and were re-admitted for similar symptoms, and on examination were positive for the presence of the same infective GI diseases. Such patients were placed in the "Chronic group". The second group was formed of patients who had previously undergone treatment for infective GI diseases but on readmission were found free of infective GI disease, and this group was described as the "Cured group". They had symptoms associated with other pathologies. A third group, which we described as the "Acute group" was composed of patients who did not have any previous case of GI infection and were admitted for the first time. Such patients were found positive on examination for infective GI diseases. In the 950 patients, we found a total of 45 tumors. The tumors were prevalent (42 tumours) in the chronic group. In 34 patients the tumor was in the colo-rectal region, in 3 patients in the stomach, in 4 patients in the oesophagus and 1 patient had cancer in the small bowel. Our results show a strong association between the chronic infection of the GI tract and the likelihood to develop tumours. However, it is not clear which biological mechanisms are implicated in such transformations. They may depend on the chronic inflammation of the GI mucous which permits the entrance of carcinogenic materials or on the effects of mutagenic products produced by the parasites or both.
Enteric infections by Schistosoma species and Entamoeba hystolitica are uncommon in the western world, while in the sub-Saharan African community these infections represent a major public health challenge (1) . The parasitic infections are endemic especially in the rural areas, where there is a poor sanitary system. Besides the clinical symptoms associated with schistosoma/entamoeba infections, e.g, weight loss, abdominal pain, alteration of bowel habits, diarrhea, enterorragy/rectorragy, anemia, jaundice (2-3), a major problem seems to be the increasing tendency to develop cancer of the GI tract. However, the distribution of infections differs with the geographical locations. The number of subjects affected increases in rural areas where there is practically no potable water and generally poor hygiene. The rural inhabitants usually drink water from rivers, wells or from poorly protected boreholes. In many rural villages there are no toilets or pit latrines and therefore such rural populations are greatly exposed to contaminations (4) and subsequently to infections by parasites and bacteria.
In the western world, Crohn's disease and ulcerative colitis are two chronic inflammatory diseases of the gastro-intestinal tract which have unknown etiopathogenesis and they are defined as chronic inflammatory bowel disease (IBD). The incidence of these diseases increases from 3 to 6 times in Caucasians compared to other races (5) (6) (7) (8) .
No cases of Crohn's disease and ulcerative colitis (IBD) are reported in the literature in sub-Saharan African community. Although other etiologic factors, e.g. obesity, smoking, diets, and genetic factors, are important and responsible for the onset of colorectal cancer. It is well documented that ulcerative colitis and Crohn's disease are important risk factors in the western population (9) (10) , therefore, we propose that it is important to investigate whether other chronic inflammatory diseases, such as Schistosomiasis and Amoebiasis can represent important risk factors for the onset of colorectal cancer.
MATERIALS AND METHODS
From Jan. 2000 to Dec. 2003, we performed a hospital population-based study in the hospitals of Mulago andArua in Uganda, and Luisa Guidotti hospital in Zimbabwe. A total of 1199 patients were admitted to these hospitals during the course of three years. Patients who presented with various gastrointestinal complaints such as abdominal pain, diarrhea, enterorrhagy/ rectorrhagy, melena, dysphagia, fever, weight loss, vomiting, alteration of bowel habits were 950. On admission, a careful history of the patients was compiled. We recorded clinical data and performed laboratory examinations on blood and stool samples obtained from all patients; we looked for haematologic alterations, such as anaemia, leukopenia, thrombocytopenia, ESR (erythrocyte sedimentation rate) elevations. In the stools we focused our attention on traces of blood, presence of trophozoids, parasites or their ova. Then we performed physical exams for abdominal tenderness, masses, ascites, hepatosplenomegaly, jaundice and recto-digital exploration was also performed to complete the physical investigations. We evaluated Body Mass Index (BMI), weight loss «or>5%) and fever «or> 38°) in every patient. We searched for the clinical files of all the patients who had previously been admitted to these hospitals, and we integrated the information obtained with our clinical findings. We based our study on all the signs and symptoms related to acute or chronic gastrointestinal pathologies. We investigated if the patients were living in rnral or urban areas. The patients who were admitted for pathologies other than GI disease did not undergo further evaluation and they were considered as the control group. The remaining group found positive during physical and/or laboratory investigations, underwent imaging or endoscopy examinations with or without biopsy.
On the bases of the clinical data, laboratory findings and physical examinations, we chose the most appropriate type of radiologic and/or endoscopic investigations:
Plain X-ray examination was performed on all 950 patients Barium enema was supplied in 302 patients, where plain X-ray showed signs of obstruction of the gut and in all patients who had no obstructive signs but continued to complain of weight loss, alteration of bowel habits, melena, diarrhoea, anaemia, fever, enterorrhagy/rectorrhagy. Where necessary, doublecontrast x-ray images of the small bowel were done.
We performed ultrasound in 411 patients who presented with jaundice, hepatosplenomegaly, epigastric pain/tenderness, and/or had positive Murphy and Giordano signs. Cytological examinations were also done on ascitis aspirated from the peritoneum cavity.
Pancolonoscopy was performed in 144 patients to evaluate the nature of lesions previously diagnosed by imaging and/or in patients who suffered from gastrointestinal bleeding and this technique also permitted biopsy of tissue samples for a histological examination.
Esophagogastroduodenoscopy was done in 216 patients who complained of dysphagia, haematemesis, epigastric pain and/or symptoms suspected for reflux disease.
Of 1199 persons, 249 subjects belonged to the control group, the remaining 950 were divided according to the stage of the enteropathy as follows:
350 patients were in a chronic phase of disease, that is, they had previously been admitted, once or twice, treated and discharged with the diagnosis of schistosomiasis (105 patients), amoebiasis (95 patients), intestinal tuberculosis (15 patients), or oesophageal candidiasis (5 patients). These patients tested positive for the same parasites and pathologies listed above on their re-admission. In the same group we also included another 130 patients previously admitted for GI symptoms, but tested negative throughout the course of their admissions for infective GI disease. So we considered them as belonging to aspecific enterocolitis group.
All these 350 patients were therefore described as chronic bearers of disease. All clinical features of the "chronic group" were compared with the control group. These data are summarized in Table I .
Patients previously admitted, treated and discharged for the presence of the above named pathologies were 150. On their re-admission they were found free of Schistosomiasis, amoebiasis and other infective GI diseases, but they had symptoms associated with other pathologies. Such patients were therefore considered apparently cured from their previous illness. 450 patients were admitted for the first time (no previous clinical history was available in the hospitals) and were found positive for the presence of the above named parasites. This group was defined as having acute disease. All clinical features of patients belonging to the acute group were compared with the features of patients in the control group. These data are summarized in Table II. Out of950 patients, 45 tumours were found. The data are presented as mean values ±SD. Differences between mean values were probed by the two tailed t-test, while differences between proportions were probed by X 2. Significance level was cut off at p::;0.05.
RESULTS
Features of the population studied are summarised in Tables I-V. In the whole sample of 1199 persons, 249 subjects were free of GI disease and therefore acted as the control group. Their mean age was 43.2±4.2 (122 males and 127 females). No tumour was found in the control group.
Out of 350 patients with chronic disease, 42 patients (12%) developed cancers (18 male and 24 female patients); 20 in the sigmoid colon-rectum, 14 in the colon, 1 in the small bowel, 3 in the stomach and 4 in the oesophagus. While in 450 patients with acute disease we found 2 tumours (0,44%); 1 in the small bowel and 1 in the stomach (1 male and 1 female patients) and in a set of 150 cured patients only 1 patient (female) had cancer, located in the stomach (0,66%). In a total number of 1199 persons who were studied, 45 tumours were found (3,74%). Of the 45 tumours, 34 were located in the large bowel, i.e, 14 in the colon, 20 in the sigma-rectum; 2 were found in the small bowel; 5 were located in the stomach and 4 were found in the oesophagus. The highest number of tumours was found in patients affected by chronic infective disease caused by schistosomiasis and amoebiasis and these were mostly located in the large bowel. Only a few cases of cancer involved the other tracts of the GI.
The details are as follows:
The chronic bearers of parasitic disease were 350, mean age 44.2±4.6. (159 males, 191 females).
In the chronic group, 105 patients were affected by Schistosomiasis (47 male and 58 female patients). The mean age in this group was 45.4±4.5.
In the same group we found 21 tumours (8 male and 13 female patients), mean age 44.8±5. Cancer of the colon was present in 9 patients and 12 patients had cancers in the sigmoid colon-rectum.
Chronic amoebiasis affected 95 patients (43 male and 52 female patients), mean age 43.6±4.4. In chronic amoebiasis group we found 13 tumours (6 males and 7 female patients). The mean age of patients with cancer was 43.7±4.8. We found 1 tumour in the stomach, 5 were located in the colon and 7 in the sigmoid colon-rectum. Chronic intestinal TBC affected 15 patients (11 male and 4 females), mean age 43.7±5. We found 1 tumour in a male patient. The patient was 39 years old. Features of cured patients are summarized in Table V . We compared the incidence of cancers (42 tumors) in the group of bearers of chronic parasitic disease (350 patients) with: the incidence of cancers (0 tumors) in the control group (249 patients); the incidence of cancers (2) in the group of patients affected by acute parasitic disease (450 patients); the incidence of cancers (1) in the group of patients cured from parasitic disease (150 patients); the incidence of cancers (3) in a group composed of acute patients, plus cured patients, plus control group (849 patients).
The results of all these comparisons were probed by X 2 and were constantly statistically significant (P=O.OOO).
As shown in Tables III, IV 
DISCUSSION
Our results show that most of the patients affected by cancer of G-I tract were in the chronic phase of disease caused by schistosomiasis or amoebiasis. Therefore we suggest that chronic schistosomiasis/amoebiais must both be considered as risk factors for the carcinomatous transformation of the bowel epithelium. According to our observations and in literature (11-12), we suppose that some factors released by the infective agents, which are involved in the chronic inflammation pathway, are associated with the onset of gastrointestinal carcinoma. But however, it is not yet clear which biological mechanisms and changes are implicated in such transformations. The importance of inflammation in the pathogenesis of colorectal cancer has been clearly stressed by Rhodes and Campbell (13) . Moreover, in literature many studies have shown that gastrointestinal parasitosis are able to stimulate the production of many agents of inflammation in the epithelium of the intestine (14) (15) .
The decrease of apoptosis in inflammatory bowel disease (lED) (ulcerative colitis and Crohn disease) is an important factor for the onset of a cancer (16) . This decrease is dependent on the early P53 mutations (17) affecting 22% of epithelial cells compared with 10% of cells in normal controls and rising to 25% in low grade dysplasia and 37% in the presence of high grade dysplasia or cancer. Furthermore, in rectal cancers associated with schistosomiasis P53 gene mutations have been reported (18) Besides the alterations of p53 expression, glycosylation abnormalities commonly occur in lED and this can affect cell-surface and secreted glycoconjugates (19) .
This alteration in cell-surface glycosylation could lead to functionally important changes as a consequence of mucosal recruitment of intraluminal lectins, which could be of dietary or microbial origin and these changes could be important in the evolution of the inflammatory process in cancer onset.
Also the over expression of prostaglandin generated by cyclo-oxygenase on its substrate, the arachidonic acid, seems interesting. COX2 activity is associated with the inhibition of apoptosis and the enhancement of angiogenesis and both these effects are associated with cancer onset (20) . It is important to stress that in colitis-associated dysplasia and cancer there is evidence of increased COX2 expression. This aspect could be an important turning point in medical practice in the future (21) .
Apoptosis has a critical role in the removal of cells carrying potentially carcinogenic mutations. The p53 tumor suppressor protein has a very important role in the negative regulation of cell proliferation, the maintenance of genomic stability, the suppression of transformation and carcinogenesis.
Macrophage migration inhibitory factor (MIF), a pro-inflammatory cytokine, involved in the promotion of tumor cell growth and associated angiogenesis (22) , is capable of inactivating p53 and could be a mechanism for the apparent failure of apoptosis in lED associated cancers.
In our next study we will evaluate the correlation of each inflammatory agent with the onset of cancer of the GI tract.
Rhodes and Campbel (13) conclude that the increased risk of cancer in the lED is a consequence of inflammation probably mediated by its effects on cytokines and hence on prostaglandin metabolism, apoptosis and glycosylation.
They also conclude that inflammation is very likely the bases of the pathogenesis of recto-colic cancer and that Virchow's assertion (23) that cancer generally results from inflammation could eventually be proved correct.
We suppose that our experience, which shows the importance of other inflammatory pathologies such as amoebiasis and schistosomiasis in the onset of colorectal cancer, could add further evidence in proving this hypothesis correct.
The transformation into cancer requires that the insult on the wall of the gut by Schistosomiasis/Amoebiasis must be continuous and enduring. As shown by the total number of cancers found, Schistosomiasis is first, followed by Amoebiasis and esophageal candidiasis. According to our results, we generally accept that the incidence of developing cancer is higher in subjects with chronic state of bowel inflammatory disease compared to the normal population. We also found two cancers in patients affected by acute parasitic disease, only one cancer in the group of cured patients and no cancers in the control group. Most of the tumours (34 cases) were found to be located in the colon and rectum, in patients affected by schistosomiasis and amoebiasis. This further supports the fact that schistosomiasis and amoebiasis are very important risk factors connected to the carcinomatous transformation of the bowel (12, (24) (25) (26) . Our patients with chronic parasitic disease who developed cancers had a lower medium age (43.9±5) compared to the Caucasian patients studied for sporadic cancer of the GI tract (65 years) (13), but similar to the age of Caucasians suffering from IBD who developed cancers (43 years for Ulcerative colitis and 54 years for Crohn's disease) (27) . We can therefore conclude that, the low median age, combined with a non familiarity factor, strongly suggests a possible association of these tumours with chronic infectious diseases of the GI tract.
